$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
Prev. Close
About Aimmune Therapeutics, Inc.
Engages in the development of desensitization treatments for peanut and other food allergies
Sector
Health Technology
CEO
Jayson Donald Alexander Dallas
Industry
Biotechnology
Exchange
NAS
Website
Top Stories
Coming soon.